C Garrison Fathman - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
Immunology, Neuroscience Biology, Molecular Biology

183 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Fathman CG, Yip L, Gómez-Martín D, Yu M, Seroogy CM, Hurt CR, Lin JT, Jenks JA, Nadeau KC, Soares L. How GRAIL controls Treg function to maintain self-tolerance. Frontiers in Immunology. 13: 1046631. PMID 36569931 DOI: 10.3389/fimmu.2022.1046631  0.397
2016 Kodama K, Zhao Z, Toda K, Yip L, Fuhlbrigge R, Miao D, Fathman CG, Yamada S, Butte AJ, Yu L. Expression-based Genome-Wide Association Study Links Vitamin D Binding Protein with Autoantigenicity in Type 1 Diabetes. Diabetes. PMID 26983959 DOI: 10.2337/Db15-1308  0.411
2016 Creusot RJ, Battaglia M, Roncarolo MG, Fathman CG. Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes. Stem Cells (Dayton, Ohio). 34: 809-19. PMID 26840009 DOI: 10.1002/Stem.2290  0.302
2015 Kurnellas MP, Ghosn EE, Schartner JM, Baker J, Rothbard JJ, Negrin RS, Herzenberg LA, Fathman CG, Steinman L, Rothbard JB. Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 26621719 DOI: 10.1073/Pnas.1521206112  0.404
2015 Nair N, Mei HE, Chen SY, Hale M, Nolan GP, Maecker HT, Genovese M, Fathman CG, Whiting CC. Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy. Arthritis Research & Therapy. 17: 127. PMID 25981462 DOI: 10.1186/S13075-015-0644-Z  0.32
2015 Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. Pillars article: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000. 100: 655-669. Journal of Immunology (Baltimore, Md. : 1950). 194: 2961-75. PMID 25795787  0.727
2015 Yip L, Fuhlbrigge R, Taylor C, Creusot RJ, Nishikawa-Matsumura T, Whiting CC, Schartner JM, Akter R, von Herrath M, Fathman CG. Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes. Diabetes. 64: 604-17. PMID 25187368 DOI: 10.2337/Db14-0803  0.339
2014 Kurnellas MP, Schartner JM, Fathman CG, Jagger A, Steinman L, Rothbard JB. Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease. The Journal of Experimental Medicine. 211: 1847-56. PMID 25073790 DOI: 10.1084/Jem.20140107  0.353
2014 Yip L, Fathman CG. Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis. Immunologic Research. 58: 340-50. PMID 24682832 DOI: 10.1007/S12026-014-8501-8  0.349
2014 Creusot RJ, Giannoukakis N, Trucco M, Clare-Salzler MJ, Fathman CG. It's time to bring dendritic cell therapy to type 1 diabetes. Diabetes. 63: 20-30. PMID 24357690 DOI: 10.2337/Db13-0886  0.467
2013 Yip L, Taylor C, Whiting CC, Fathman CG. Diminished adenosine A1 receptor expression in pancreatic α-cells may contribute to the pathology of type 1 diabetes. Diabetes. 62: 4208-19. PMID 24264405 DOI: 10.2337/Db13-0614  0.329
2013 Yip L, Creusot RJ, Pager CT, Sarnow P, Fathman CG. Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3. Journal of Molecular Cell Biology. 5: 99-110. PMID 22923498 DOI: 10.1093/Jmcb/Mjs052  0.347
2012 Junttila IS, Creusot RJ, Moraga I, Bates DL, Wong MT, Alonso MN, Suhoski MM, Lupardus P, Meier-Schellersheim M, Engleman EG, Utz PJ, Fathman CG, Paul WE, Garcia KC. Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nature Chemical Biology. 8: 990-8. PMID 23103943 DOI: 10.1038/Nchembio.1096  0.351
2012 Maecker HT, Lindstrom TM, Robinson WH, Utz PJ, Hale M, Boyd SD, Shen-Orr SS, Fathman CG. New tools for classification and monitoring of autoimmune diseases. Nature Reviews. Rheumatology. 8: 317-28. PMID 22647780 DOI: 10.1038/Nrrheum.2012.66  0.31
2012 Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, Moraga I, Raeber ME, Bowman GR, Novick P, Pande VS, Fathman CG, Boyman O, Garcia KC. Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature. 484: 529-33. PMID 22446627 DOI: 10.1038/Nature10975  0.394
2012 Lin JT, Stein EA, Wong MT, Kalpathy KJ, Su LL, Utz PJ, Robinson WH, Fathman CG. Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis. Clinical Immunology (Orlando, Fla.). 142: 127-38. PMID 22075384 DOI: 10.1016/J.Clim.2011.09.008  0.539
2011 Whiting CC, Su LL, Lin JT, Fathman CG. GRAIL: a unique mediator of CD4 T-lymphocyte unresponsiveness. The Febs Journal. 278: 47-58. PMID 21078124 DOI: 10.1111/J.1742-4658.2010.07922.X  0.597
2010 Creusot RJ, Chang P, Healey DG, Tcherepanova IY, Nicolette CA, Fathman CG. A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 2112-20. PMID 20628358 DOI: 10.1038/Mt.2010.146  0.388
2010 Fathman CG. Correction: omitted author. Science (New York, N.Y.). 260: 280. PMID 17838233 DOI: 10.1126/Science.260.5106.280-A  0.416
2010 Lin J, Stein E, Wong M, Kalpathy K, Su L, Utz P, Robinson W, Fathman C. Targeting mTOR and MAPK Pathways to Inhibit Naïve and Experienced Effector CD4 T Cells in Autoimmunity Clinical Immunology. 135: S69. DOI: 10.1016/J.Clim.2010.03.211  0.435
2009 Su LL, Iwai H, Lin JT, Fathman CG. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 438-44. PMID 19542455 DOI: 10.4049/Jimmunol.0900204  0.533
2009 Lin JT, Lineberry NB, Kattah MG, Su LL, Utz PJ, Fathman CG, Wu L. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression. Journal of Immunology (Baltimore, Md. : 1950). 182: 5919-28. PMID 19414743 DOI: 10.4049/Jimmunol.0803986  0.811
2009 Zhou B, Kermany M, Zhou Y, Cai C, Cai Q, Tarner I, Fathman C, Kim P, Kim J, Liu W. Adoptive Immunotherapy of Experimental Autoimmune Hearing Loss via T Cell Delivery of the IL-12 p40 Subunit Journal of Allergy and Clinical Immunology. 123: S208-S208. DOI: 10.1016/j.jaci.2008.12.793  0.316
2009 Acharya S, Fathman CG. F.124. CTLA-4 Ig Serves as a Surrogate for Tregs by Engaging Activation Induced CD80/86 on Murine T Effector Cells Clinical Immunology. 131: S127. DOI: 10.1016/J.Clim.2009.03.375  0.525
2009 Su L, Iwai H, Lin J, Fathman CG. F.80. The TransmembraneE3 Ligase, GRAIL Ubiquitinates and Degrades CD83 on CD4+ T cells Clinical Immunology. 131: S115. DOI: 10.1016/J.Clim.2009.03.338  0.468
2009 Creusot R, Chang P, Yaghoubi S, Healey D, Tcherepanova I, Nicolette C, Fathman CG. T.14. A Short Pulse of IL-4 Delivered Locally by mRNA Electroporated DCs is Sufficient to Prevent or Treat Autoimmune Diabetes in NOD Mice Clinical Immunology. 131: S53. DOI: 10.1016/J.Clim.2009.03.149  0.372
2009 Lin J, Lineberry N, Kattah M, Su L, Utz P, Fathman CG. OR.85. Regulation of GRAIL Expression by mTOR Controls Naive CD4 T Cell Proliferation Clinical Immunology. 131: S35-S36. DOI: 10.1016/J.Clim.2009.03.100  0.809
2008 Kodama K, Butte AJ, Creusot RJ, Su L, Sheng D, Hartnett M, Iwai H, Soares LR, Fathman CG. Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clinical Immunology (Orlando, Fla.). 129: 195-201. PMID 18801706 DOI: 10.1016/J.Clim.2008.07.028  0.307
2008 Lineberry N, Su L, Soares L, Fathman CG. The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane. The Journal of Biological Chemistry. 283: 28497-505. PMID 18713730 DOI: 10.1074/Jbc.M805092200  0.75
2008 Lineberry NB, Su LL, Lin JT, Coffey GP, Seroogy CM, Fathman CG. Cutting edge: The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 181: 1622-6. PMID 18641297 DOI: 10.4049/Jimmunol.181.3.1622  0.826
2008 Creusot RJ, Yaghoubi SS, Kodama K, Dang DN, Dang VH, Breckpot K, Thielemans K, Gambhir SS, Fathman CG. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clinical Immunology (Orlando, Fla.). 127: 176-87. PMID 18337172 DOI: 10.1016/J.Clim.2007.12.009  0.333
2008 Creusot R, Chang P, Fathman C. Sa.86. The Earliest Islet-infiltrating T Cells in NOD Mice Clinical Immunology. 127: S108-S109. DOI: 10.1016/j.clim.2008.03.307  0.385
2007 Yaghoubi SS, Creusot RJ, Ray P, Fathman CG, Gambhir SS. Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: image-based estimation of the number of cells accumulating in mouse paws. Journal of Biomedical Optics. 12: 064025. PMID 18163841 DOI: 10.1117/1.2821415  0.427
2007 Dutt S, Tseng D, Ermann J, George TI, Liu YP, Davis CR, Fathman CG, Strober S. Naive and memory T cells induce different types of graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 179: 6547-54. PMID 17982043 DOI: 10.4049/Jimmunol.179.10.6547  0.52
2007 Li J, Ridgway W, Fathman CG, Tse HY, Shaw MK. High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 192: 57-67. PMID 17920698 DOI: 10.1016/J.Jneuroim.2007.09.004  0.555
2007 Fathman CG, Lineberry NB. Molecular mechanisms of CD4+ T-cell anergy. Nature Reviews. Immunology. 7: 599-609. PMID 17612584 DOI: 10.1038/Nri2131  0.821
2007 Schartner JM, Fathman CG, Seroogy CM. Preservation of self: an overview of E3 ubiquitin ligases and T cell tolerance. Seminars in Immunology. 19: 188-96. PMID 17403607 DOI: 10.1016/J.Smim.2007.02.010  0.413
2007 MacKenzie DA, Schartner J, Lin J, Timmel A, Jennens-Clough M, Fathman CG, Seroogy CM. GRAIL is up-regulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. The Journal of Biological Chemistry. 282: 9696-702. PMID 17259178 DOI: 10.1074/Jbc.M604192200  0.588
2007 Creusot RJ, Yaghoubi S, Kodama K, Gambhir SS, Dang D, Fathman CG. Targeted Cellular Gene Therapy Using IL-4 Secreting DCs Corrects Immune Dysregulations and Prevents Diabetes in NOD Mice Clinical Immunology. 123: S17. DOI: 10.1016/J.Clim.2007.03.218  0.323
2007 Iwai H, Kodama K, Dang D, Fathman CG, Bluestone JA. Gene Expression Analysis by Microarray Following Anti-CD3 Antibody Therapy of NOD Mice Clinical Immunology. 123: S9. DOI: 10.1016/J.Clim.2007.03.197  0.356
2006 Su L, Lineberry N, Huh Y, Soares L, Fathman CG. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 177: 7559-66. PMID 17114425 DOI: 10.4049/Jimmunol.177.11.7559  0.798
2006 Tarner IH, Fathman CG. Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease? Nature Clinical Practice. Rheumatology. 2: 491-9. PMID 16951704 DOI: 10.1038/Ncprheum0272  0.377
2006 Lineberry N, Fathman CG. T cell anergy: where it's LAT. Immunity. 24: 501-3. PMID 16713965 DOI: 10.1016/J.Immuni.2006.05.002  0.806
2006 Lineberry N, Fathman CG. CYLD: deubiquitination-induced TCR signaling. Nature Immunology. 7: 369-70. PMID 16550202 DOI: 10.1038/Ni0406-369  0.76
2006 Tarner IH, Neumann E, Gay S, Fathman CG, Müller-Ladner U. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis. Autoimmunity Reviews. 5: 148-52. PMID 16431349 DOI: 10.1016/J.Autrev.2005.09.009  0.301
2006 Randolph DA, Fathman CG. Cd4+Cd25+ regulatory T cells and their therapeutic potential. Annual Review of Medicine. 57: 381-402. PMID 16409156 DOI: 10.1146/Annurev.Med.57.121304.131337  0.554
2006 Dutt S, Tseng D, George TI, Ermann J, Liu Y, Fathman CG, Strober S. Allosensitized Memory CD4 T Cells Induce Chronic Graft Versus Host Disease. Blood. 108: 449-449. DOI: 10.1182/Blood.V108.11.449.449  0.498
2006 Lineberry N, Fathman CG. T Cell Anergy: Where It's LAT (DOI:10.1016/j.immuni.2006.05.002) Immunity. 25: 175. DOI: 10.1016/J.Immuni.2006.07.008  0.792
2005 Creusot RJ, Fathman CG, Müller-Ladner U, Tarner IH. Targeted gene therapy of autoimmune diseases: advances and prospects. Expert Review of Clinical Immunology. 1: 385-404. PMID 20476990 DOI: 10.1586/1744666X.1.3.385  0.304
2005 Dutt S, Ermann J, Tseng D, Liu YP, George TI, Fathman CG, Strober S. L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood. 106: 4009-15. PMID 16105972 DOI: 10.1182/Blood-2005-06-2339  0.504
2005 Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP, Negrin RS, Fathman CG, Strober S. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood. 105: 2220-6. PMID 15546950 DOI: 10.1182/Blood-2004-05-2044  0.48
2005 Jamieson C, Karimi M, Creusot R, Negrin R, Gotlib J, Chao M, Jones C, Keating A, Fathman CG, Zehnder J, Weissman IL. Bioluminescent Imaging of Human Leukemic Stem Cell Engraftment. Blood. 106: 696-696. DOI: 10.1182/Blood.V106.11.696.696  0.362
2005 Dutt S, Tseng D, Ermann J, Liu YP, George TI, Fathman CG, Strober S. Memory CD4 T Cells Induce Graft Versus Host Disease. Blood. 106: 1309-1309. DOI: 10.1182/Blood.V106.11.1309.1309  0.508
2004 Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. Protein microarrays for multiplex analysis of signal transduction pathways. Nature Medicine. 10: 1390-6. PMID 15558056 DOI: 10.1038/Nm1139  0.491
2004 Su L, Creusot RJ, Gallo EM, Chan SM, Utz PJ, Fathman CG, Ermann J. Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene. Journal of Immunology (Baltimore, Md. : 1950). 173: 4994-5001. PMID 15470042 DOI: 10.4049/Jimmunol.173.8.4994  0.501
2004 Creusot RJ, Fathman CG. Gene therapy for type 1 diabetes: a novel approach for targeted treatment of autoimmunity. The Journal of Clinical Investigation. 114: 892-4. PMID 15467826 DOI: 10.1172/Jci23168  0.446
2004 Jeon MS, Atfield A, Venuprasad K, Krawczyk C, Sarao R, Elly C, Yang C, Arya S, Bachmaier K, Su L, Bouchard D, Jones R, Gronski M, Ohashi P, Wada T, ... Fathman CG, et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction Immunity. 21: 167-177. PMID 15308098 DOI: 10.1016/J.Immuni.2004.07.013  0.489
2004 Seroogy CM, Soares L, Ranheim EA, Su L, Holness C, Bloom D, Fathman CG. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 79-85. PMID 15210761 DOI: 10.4049/Jimmunol.173.1.79  0.609
2004 Soares L, Seroogy C, Skrenta H, Anandasabapathy N, Lovelace P, Chung CD, Engleman E, Fathman CG. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nature Immunology. 5: 45-54. PMID 14661020 DOI: 10.1038/Ni1017  0.769
2003 Seroogy CM, Fathman CG. T-cell anergy: from phenotype to genotype and back. Immunologic Research. 28: 255-64. PMID 14713718 DOI: 10.1385/Ir:28:3:255  0.466
2003 Ermann J, Chung CD, Fathman CG. Scratching the (T cell) surface. Genome Biology. 5: 202. PMID 14709166 DOI: 10.1186/Gb-2003-5-1-202  0.535
2003 Ermann J, Fathman CG. Costimulatory signals controlling regulatory T cells. Proceedings of the National Academy of Sciences of the United States of America. 100: 15292-3. PMID 14676329 DOI: 10.1073/Pnas.0307001100  0.53
2003 Tarner IH, Slavin AJ, McBride J, Levicnik A, Smith R, Nolan GP, Contag CH, Fathman CG. Treatment of autoimmune disease by adoptive cellular gene therapy. Annals of the New York Academy of Sciences. 998: 512-9. PMID 14592922 DOI: 10.1196/Annals.1254.067  0.526
2003 Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine. 9: 1144-50. PMID 12925844 DOI: 10.1038/Nm915  0.516
2003 Anandasabapathy N, Ford GS, Bloom D, Holness C, Paragas V, Seroogy C, Skrenta H, Hollenhorst M, Fathman CG, Soares L. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity. 18: 535-47. PMID 12705856 DOI: 10.1016/S1074-7613(03)00084-0  0.77
2002 Slavin AJ, Tarner IH, Nakajima A, Urbanek-Ruiz I, McBride J, Contag CH, Fathman CG. Adoptive cellular gene therapy of autoimmune disease. Autoimmunity Reviews. 1: 213-9. PMID 12848998 DOI: 10.1016/S1568-9972(02)00051-4  0.533
2002 McBride JM, Fathman CG. A complicated relationship: fulfilling the interactive needs of the T lymphocyte and the dendritic cell. The Pharmacogenomics Journal. 2: 367-76. PMID 12629502 DOI: 10.1038/sj.tpj.6500145  0.492
2002 Tarner IH, Nakajima A, Seroogy CM, Ermann J, Levicnik A, Contag CH, Fathman CG. Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. Clinical Immunology (Orlando, Fla.). 105: 304-14. PMID 12498812 DOI: 10.1006/Clim.2002.5299  0.379
2002 Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, Lejon K, Fathman CG, Mueller SN, Shortman K, Carbone FR, Heath WR. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. The Journal of Experimental Medicine. 196: 1099-104. PMID 12391021 DOI: 10.1084/Jem.20020861  0.45
2002 Oh JW, Seroogy CM, Meyer EH, Akbari O, Berry G, Fathman CG, Dekruyff RH, Umetsu DT. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. The Journal of Allergy and Clinical Immunology. 110: 460-8. PMID 12209095 DOI: 10.1067/Mai.2002.127512  0.522
2002 Szanya V, Ermann J, Taylor C, Holness C, Fathman CG. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. Journal of Immunology (Baltimore, Md. : 1950). 169: 2461-5. PMID 12193715 DOI: 10.4049/Jimmunol.169.5.2461  0.431
2002 Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. The Journal of Experimental Medicine. 196: 389-99. PMID 12163567 DOI: 10.1084/Jem.20020399  0.52
2001 Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH. Bioluminescence imaging of lymphocyte trafficking in vivo. Experimental Hematology. 29: 1353-60. PMID 11750093 DOI: 10.1016/S0301-472X(01)00756-1  0.355
2001 Tarner IH, Fathman CG. Gene therapy in autoimmune disease. Current Opinion in Immunology. 13: 676-82. PMID 11677089 DOI: 10.1016/S0952-7915(01)00278-3  0.377
2001 Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 167: 4271-5. PMID 11591749 DOI: 10.4049/Jimmunol.167.8.4271  0.518
2001 Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, Slavin AJ, Contag CH, Fathman CG, Benson JM. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. Journal of Immunology (Baltimore, Md. : 1950). 167: 2379-87. PMID 11490028 DOI: 10.4049/Jimmunol.167.4.2379  0.793
2001 Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. The Journal of Clinical Investigation. 107: 1293-301. PMID 11375419 DOI: 10.1172/Jci12037  0.795
2001 Slavin AJ, Fathman CG. Retroviral-mediated gene therapy in autoimmune disease Canadian Journal of Allergy and Clinical Immunology. 6: 236-242.  0.508
2000 Fassò M, Anandasabapathy N, Crawford F, Kappler J, Fathman CG, Ridgway WM. T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. The Journal of Experimental Medicine. 192: 1719-30. PMID 11120769 DOI: 10.1084/Jem.192.12.1719  0.766
2000 Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100: 655-69. PMID 10761931 DOI: 10.1016/S0092-8674(00)80702-3  0.762
2000 Fathman CG, Costa GL, Seroogy CM. Gene therapy for autoimmune disease. Clinical Immunology (Orlando, Fla.). 95: S39-43. PMID 10729236 DOI: 10.1006/Clim.1999.4812  0.79
2000 Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 164: 3581-90. PMID 10725713 DOI: 10.4049/Jimmunol.164.7.3581  0.8
2000 Skrenta H, Yang Y, Pestka S, Fathman CG. Ligand-independent down-regulation of IFN-gamma receptor 1 following TCR engagement. Journal of Immunology (Baltimore, Md. : 1950). 164: 3506-11. PMID 10725704 DOI: 10.4049/Jimmunol.164.7.3506  0.518
2000 Krieger NR, Fathman CG, Shaw MK, Ridgway WM. Identification and characterization of the antigen-specific subpopulation of alloreactive CD4+ T cells in vitro and in vivo. Transplantation. 69: 605-9. PMID 10708118  0.494
2000 Seroogy CM, Fathman CG. The application of gene therapy in autoimmune diseases. Gene Therapy. 7: 9-13. PMID 10680009 DOI: 10.1038/sj.gt.3301111  0.407
1999 Ridgway WM, Fathman CG. MHC structure and autoimmune T cell repertoire development. Current Opinion in Immunology. 11: 638-42. PMID 10631548 DOI: 10.1016/S0952-7915(99)00030-8  0.412
1999 Lejon K, Fathman CG. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. Journal of Immunology (Baltimore, Md. : 1950). 163: 5708-14. PMID 10553102  0.486
1999 Ruiz PJ, Garren H, Ruiz IU, Hirschberg DL, Nguyen LV, Karpuj MV, Cooper MT, Mitchell DJ, Fathman CG, Steinman L. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. Journal of Immunology (Baltimore, Md. : 1950). 162: 3336-41. PMID 10092787  0.354
1999 Dal Canto RA, Shaw MK, Nolan GP, Steinman L, Fathman CG. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis. Clinical Immunology (Orlando, Fla.). 90: 10-4. PMID 9884347 DOI: 10.1006/Clim.1998.4653  0.456
1998 Ridgway WM, Ito H, Fassò M, Yu C, Fathman CG. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response. The Journal of Experimental Medicine. 188: 2267-75. PMID 9858513 DOI: 10.1084/Jem.188.12.2267  0.495
1998 Dal Canto RA, Costa G, Shaw MD, Seroogy C, Nolan GP, Fathman CG. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis. European Cytokine Network. 9: 83-91. PMID 9831193  0.392
1998 Ridgway W, Fassò M, Fathman CG. Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. Journal of Immunology (Baltimore, Md. : 1950). 161: 714-20. PMID 9670947  0.487
1998 Yang Y, Chang JF, Parnes JR, Fathman CG. T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA. The Journal of Experimental Medicine. 188: 247-54. PMID 9670037 DOI: 10.1084/Jem.188.2.247  0.449
1998 Charlton B, Fathman CG, Slattery RM. Th1 unresponsiveness can be infectious for unrelated antigens. Immunology and Cell Biology. 76: 173-8. PMID 9619488 DOI: 10.1046/j.1440-1711.1998.00728.x  0.351
1998 Yang Y, Kim D, Fathman CG. Regulation of programmed cell death following T cell activation in vivo. International Immunology. 10: 175-83. PMID 9533445 DOI: 10.1093/intimm/10.2.175  0.411
1998 Ridgway WM, Fathman CG. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clinical Immunology and Immunopathology. 86: 3-10. PMID 9434791 DOI: 10.1006/Clin.1997.4449  0.421
1998 Dal Canto R, Costa G, Steinman L, Dal Canto M, Fathman C. Experimental “autoimmune” versus “allergic” encephalomyelitis Journal of Neuroimmunology. 90: 4. DOI: 10.1016/S0165-5728(98)91215-2  0.606
1998 Ridgway W, Fassò M, Fathman CG. Following antigen challenge, T cells upregulate cell surface expression of CD4 in vitro and in vivo Faseb Journal. 12.  0.514
1998 Bloom DD, Yang Y, Moore BB, Fathman CG. The induction of T lymphocyte anergy: Ras dependence and IL-2 transcription revisited Faseb Journal. 12.  0.323
1997 Ito H, Fathman CG. CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease. Journal of Autoimmunity. 10: 455-9. PMID 9376073 DOI: 10.1016/S0896-8411(97)90152-9  0.426
1997 Krieger NR, Ito H, Fathman CG. Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice. Journal of Autoimmunity. 10: 309-15. PMID 9218759 DOI: 10.1006/Jaut.1997.0126  0.4
1997 Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, Fathman CG. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 185: 1711-4. PMID 9151908 DOI: 10.1084/Jem.185.9.1711  0.493
1997 Krieger NR, Fathman CG. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 16: 263-7. PMID 9087868  0.391
1996 Shimada A, Charlton B, Rohane P, Taylor-Edwards C, Fathman CG. Immune regulation in type 1 diabetes Journal of Autoimmunity. 9: 263-269. PMID 8738972 DOI: 10.1006/jaut.1996.0033  0.32
1996 Yang Y, Charlton B, Shimada A, Dal Canto R, Fathman CG. Monoclonal T cells identified in early NOD islet infiltrates Immunity. 4: 189-194. PMID 8624809 DOI: 10.1016/S1074-7613(00)80683-4  0.524
1996 Kim DT, Rothbard JB, Bloom DD, Fathman CG. Quantitative analysis of T cell activation: Role of TCR/ligand density and TCR affinity Journal of Immunology. 156: 2737-2742. PMID 8609391  0.421
1996 Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N, Mitchell D, Veromaa T, Waisman A, Gaur A, Conlon P, Ling N, ... Fathman CG, et al. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature. 379: 343-6. PMID 8552189 DOI: 10.1038/379343a0  0.407
1995 Fathman CG. Ternary complex therapy for autoimmune disease Hospital Practice. 30. PMID 7635912  0.325
1994 Gelber C, Paborsky L, Singer S, Mcateer D, Tisch R, Jolicoeur C, Buelow R, Mcdevitt H, Fathman CG. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes Diabetes. 43: 33-39. PMID 8262314  0.34
1994 Charlton B, Meltzer J, Fathman CG. CD4-positive/heat-stable antigen-positive thymocytes cause graft-versus-host disease across non-major histocompatibility complex incompatibilities. European Journal of Immunology. 24: 1706-9. PMID 7913040 DOI: 10.1002/Eji.1830240738  0.496
1994 Charlton B, Edwards CT, Tisch R, Fathman CG. Prevention of Diabetes and Insulitis by Neonatal Intrathymic Islet Administration in NOD Mice Journal of Autoimmunity. 7: 549-560. PMID 7840850 DOI: 10.1006/Jaut.1994.1040  0.39
1994 Ridgway WM, Weiner HL, Fathman CG. Regulation of autoimmune response Current Opinion in Immunology. 6: 946-955. PMID 7710719 DOI: 10.1016/0952-7915(94)90018-3  0.442
1993 Song HK, Alters SE, Fathman CG. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice1 Transplantation. 55: 133-139. PMID 8420037  0.359
1993 Gaur A, Haspel R, Mayer JP, Fathman CG. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness Science. 259: 91-94. PMID 8418501 DOI: 10.1126/science.8418501  0.445
1993 Alters SE, Song HK, Fathman CG. Evidence that clonal anergy is induced in thymic migrant cells after anti-cd4-mediated transplantation tolerance Transplantation. 56: 633-638. PMID 8212161 DOI: 10.1097/00007890-199309000-00026  0.378
1993 Brocke S, Gaur A, Piercy C, Gautam A, Gijbels K, Fathman CG, Steinman L. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen Nature. 365: 642-644. PMID 7692305 DOI: 10.1038/365642A0  0.499
1993 Gaur A, Fathman CG, Steinman L, Brocke S. SEB induced anergy: Modulation of immune response to T cell determinants of myoglobin and myelin basic protein Journal of Immunology. 150: 3062-3069. PMID 7681087  0.456
1992 Fathman CG. What a rheumatologist needs to know about T cell receptor structure and function Journal of Rheumatology. 19: 12-15. PMID 1613729  0.393
1992 Shizuru JA, Alters SE, Fathman CG. Anti-CD4 monoclonal antibodies in therapy: Creation of nonclassical tolerance in the adult Immunological Reviews. 105-130. PMID 1361179 DOI: 10.1111/J.1600-065X.1992.Tb01421.X  0.465
1991 Ruberti G, Gaur A, Fathman CG, Livingstone AM. The T cell receptor repertoire influences Vβ element usage in response to myoglobin Journal of Experimental Medicine. 174: 83-92. PMID 2056283  0.353
1991 Alters SE, Shizuru JA, Ackerman J, Grossman D, Seydel KB, Fathman CG. Anti-CD4 mediates clonal anergy during transplantation tolerance induction Journal of Experimental Medicine. 173: 491-494. PMID 1899105 DOI: 10.1084/Jem.173.2.491  0.364
1991 Seydel K, Shizuru J, Grossman D, Wu A, Alters S, Fathman CG. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model Diabetes. 40: 1430-1434. PMID 1834499 DOI: 10.2337/Diab.40.11.1430  0.353
1991 Shizuru JA, Taylor-Edwards C, Livingstone A, Fathman CG. Genetic dissection of T cell receptor Vβ gene requirements for spontaneous murine diabetes Journal of Experimental Medicine. 174: 633-638. PMID 1831491 DOI: 10.1084/Jem.174.3.633  0.345
1991 Ruberti G, Livingstone A, Danska JS, Gaur A, Fathman CG. Analysis of the ternary complex of antigen, MHC and T-cell receptor: the influence of the T-cell receptor Vβ repertoire on the Vβ gene element usage Research in Immunology. 142: 491-493. PMID 1721721 DOI: 10.1016/0923-2494(91)90054-M  0.395
1990 Morel PA, Horn GT, Budd RC, Erlich HA, Fathman CG. Shared molecular markers of genetic predisposition to seropositive rheumatoid arthritis. Human Immunology. 27: 90-9. PMID 2298612 DOI: 10.1016/0198-8859(90)90106-Y  0.401
1990 Guidos CJ, Danska JS, Fathman CG, Weissman IL. T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages Journal of Experimental Medicine. 172: 835-845. PMID 2143774 DOI: 10.1084/Jem.172.3.835  0.372
1989 Butterfield K, Fathman CG, Budd RC. A subset of memory CD4+ helper T lymphocytes identified by expression of Pgp-1 Journal of Experimental Medicine. 169: 1461-1466. PMID 2564418  0.467
1989 Romani N, Koide S, Crowley M, Witmer-Pack M, Livingstone AM, Fathman CG, Inaba K, Steinman RM. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells Journal of Experimental Medicine. 169: 1169-1178. PMID 2522497  0.395
1989 Weyand CM, Goronzy J, Swarztrauber K, Fathman CG. Immunosuppression by anti-CD4 treatment in vivo: Cellular and humoral responses to alloantigens Transplantation. 47: 1039-1042. PMID 2472024  0.394
1989 Weyand CM, Goronzy J, Swarztrauber K, Fathman CG. Immunosuppression by anti-CD4 treatment in vivo: Persistence of secondary antiviral immune responses Transplantation. 47: 1034-1038. PMID 2472023  0.441
1989 Flavin TF, Shizuru J, Seydel K, Wu A, Hoyt EG, Ivens K, Billingham M, Fathman CG, Starnes VA. Pretransplant T-cell subset modulation confers donor-specific unresponsiveness in rats Surgical Forum. 40: 354-357.  0.362
1989 Cornelia MW, Jorg G, Kari S, Fathman CG. Immunosuppression by anti-cd4 treatment in vivo Transplantation. 47: 1034-1038.  0.396
1988 Goronzy J, Weyand C, Fathman CG. Cloning of human alloreactive T cells. Methods in Enzymology. 150: 333-41. PMID 3501522 DOI: 10.1016/0076-6879(87)50091-x  0.405
1988 Livingstone A, Fathman CG. Murine T cell clones. Methods in Enzymology. 150: 324-33. PMID 3501521 DOI: 10.1016/0076-6879(87)50090-8  0.444
1988 Morel PA, Erlich HA, Fathman CG. A new look at the shared epitope hypothesis The American Journal of Medicine. 85: 20-22. PMID 2462347 DOI: 10.1016/0002-9343(88)90375-0  0.383
1987 Morel PA, Livingstone AM, Fathman CG. Correlation of T cell receptor V(β) gene family with MHC restriction Journal of Experimental Medicine. 166: 583-588. PMID 3598467 DOI: 10.1084/JEM.166.2.583  0.339
1987 Ishihara T, Fathman CG. Production of antibodies in vitro in cultures of murine lymphocytes Methods in Enzymology. 150: 304-309. PMID 3323787 DOI: 10.1016/0076-6879(87)50087-8  0.422
1987 Goronzy J, Weyand C, Imboden J, Manger B, Fathman CG. Heterogeneity of signal requirements in T cell activation within a panel of human proliferative T cell clones Journal of Immunology. 138: 3087-3093. PMID 3106471  0.48
1987 Weyand CM, Goronzy J, Fathman CG. Modulation of CD4 by antigenic activation Journal of Immunology. 138: 1351-1354. PMID 3100638  0.476
1987 Livingstone AM, Fathman CG. The structure of T-cell epitopes Annual Review of Immunology. 5: 477-501. PMID 2439104  0.342
1986 Weyand CM, Goronzy J, Dallman MJ, Fathman CG. Administration of recombinant interleukin 2 in vivo induces a polyclonal IgM response Journal of Experimental Medicine. 163: 1607-1612. PMID 3486940  0.317
1986 Kyewski BA, Fathman CG, Rouse RV. Intrathymic presentation of circulating non-MHC antigens by medullary dendritic cells. An antigen-dependent microenvironment for T cell differentiation Journal of Experimental Medicine. 163: 231-246. PMID 3484777  0.383
1986 Goronzy J, Weyand CM, Fathman CG. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4 Journal of Experimental Medicine. 164: 911-925. PMID 3091757  0.349
1986 Shigeta M, Takahara S, Knox SJ, Ishihara T, Vitetta ES, Fathman CG. Two independent pathways of helper activity provided by a single T cell clone. Journal of Immunology (Baltimore, Md. : 1950). 136: 34-8. PMID 2933466  0.389
1986 Weyand C, Goronzy J, Fathman CG. Human t-cell, Clones as diagnostic tools and potential therapeutic reagents Immunological Investigations. 15: 591-624. PMID 2433217 DOI: 10.3109/08820138609048906  0.357
1986 Fathman CG, Goronzy J, Weyand C. Gene conversion: A mechanism to explain HLA-D region and disease association Annals of the New York Academy of Sciences. 24-31. PMID 2431644 DOI: 10.1111/J.1749-6632.1986.Tb20853.X  0.416
1986 Kimoto M, Fathman CG. One I Region Restriction Determinant Can Associate with Multiple Antigenic Epitopes Microbiology and Immunology. 30: 133-142. PMID 2423856 DOI: 10.1111/J.1348-0421.1986.Tb00928.X  0.449
1986 Goronzy J, Weyand CM, Fathman CG. Shared T cell recognition sites on human histocompatibility leukocyte antigen class II molecules of patients with seropositive rheumatoid arthritis Journal of Clinical Investigation. 77: 1042-1049. PMID 2419361  0.329
1986 Weyand CM, Goronzy J, Fathman CG. Human T-cell clones used to define functional epitopes on HLA class II molecules Proceedings of the National Academy of Sciences of the United States of America. 83: 762-766. PMID 2418442  0.343
1986 Ishihara T, Takahara S, Fathman CG. IL 2 restores memory B cell activation by antigen-specific T cell clone variants Journal of Immunology. 136: 39-43. PMID 2415626  0.406
1985 Navarro RF, Jalkanen ST, Hsu M, Søenderstrup-Hansen G, Goronzy J, Weyand C, Fathman CG, Clayberger C, Krensky AM, Butcher EC. Human T cell clones express functional homing receptors required for normal lymphocyte trafficking Journal of Experimental Medicine. 162: 1075-1080. PMID 3875680 DOI: 10.1084/jem.162.3.1075  0.389
1985 Frelinger JG, Shigeta M, Fathman CG. An analysis of monoclonal T cell and antibody recognition sites on Ia molecules Journal of Investigative Dermatology. 85. PMID 3874247 DOI: 10.1111/1523-1747.Ep12275430  0.41
1985 Nakahara K, Kaplan D, Bjorn M, Fathman CG. The effectiveness of anti–Ia–immunotoxins in the suppression of MLR Transplantation. 40: 62-67. PMID 3160144 DOI: 10.1097/00007890-198507000-00013  0.336
1985 Cunningham AL, Nelson PA, Fathman CG, Merigan TC. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis. The Journal of General Virology. 66: 249-58. PMID 2981967 DOI: 10.1099/0022-1317-66-2-249  0.414
1985 Khan MM, Melmon KL, Fathman CG, Hertel-Wulff B, Strober S. The effects of autacoids on cloned murine lymphoid cells: Modulation of IL 2 secretion and the activity of natural suppressor cells Journal of Immunology. 134: 4100-4106. PMID 2859336  0.384
1985 Goronzy J, Weyand K, Hunt T, Fathman CG. Dissection of the Dw14 specificity by human T cell clones Federation Proceedings. 44.  0.413
1984 Kyewski BA, Fathman CG, Kaplan HS. Intrathymic presentation of circulating non-major histocompatibility complex antigens Nature. 308: 196-199. PMID 6608055 DOI: 10.1038/308196A0  0.369
1984 Frelinger J, Sing A, Infante A, Fathman CG. Clonotypic antibodies which stimulate T cell clone proliferation Immunological Reviews. 21-38. PMID 6334643 DOI: 10.1111/J.1600-065X.1984.Tb01103.X  0.34
1984 Coulam CB, Silverfield JC, Kazmar RE, Fathman CG. T-lymphocyte subsets during pregnancy and the menstrual cycle. American Journal of Reproductive Immunology : Ajri : Official Journal of the American Society For the Immunology of Reproduction and the International Coordination Committee For Immunology of Reproduction. 4: 88-90. PMID 6228154 DOI: 10.1111/j.1600-0897.1983.tb00259.x  0.39
1983 Fathman CG, Frelinger JG. T-lymphocyte clones Annual Review of Immunology. 1: 633-655. PMID 6242467 DOI: 10.1146/Annurev.Iy.01.040183.003221  0.422
1983 Beck BN, Nelson PA, Fathman CG. The I-Ab mutant B6.C-H-2bm12 allows definition of multiple T cell epitopes on I-A molecules. The Journal of Experimental Medicine. 157: 1396-404. PMID 6189934  0.367
1983 Infante AJ, Atassi MZ, Fathman CG. Myoglobin-reactive T cell clones. Advances in Experimental Medicine and Biology. 150: 159-82. PMID 6183942 DOI: 10.1007/978-1-4684-4331-8_9  0.453
1982 Asano Y, Shigeta M, Fathman CG, Singer A, Hodes RJ. Role of the major histocompatibility complex in T cell activation of B cell subpopulations. A single monoclonal T helper cell population activates different B cell subpopulations by distinct pathways. The Journal of Experimental Medicine. 156: 350-60. PMID 6980253 DOI: 10.1084/jem.156.2.350  0.375
1982 Hodes RJ, Kimoto M, Hathcock KS, Fathman CG, Singer A. Functional helper activity of monoclonal T cell populations: antigen-specific and H-2 restricted cloned T cells provide help for in vitro antibody responses to trinitrophenyl-poly(LTyr,Glu)-poly(DLAla)--poly(LLys). Proceedings of the National Academy of Sciences of the United States of America. 78: 6431-5. PMID 6975940 DOI: 10.1073/pnas.78.10.6431  0.436
1982 Singer A, Asano Y, Shigeta M, Hathcock KS, Ahmed A, Fathman CG, Hodes RJ. Distinct B cell subpopulations differ in their genetic requirements for activation by T helper cells. Immunological Reviews. 64: 137-60. PMID 6806171 DOI: 10.1111/J.1600-065X.1982.Tb00422.X  0.476
1982 Shigeta M, Fathman CG. I-region genetic restrictions imposed upon the recognition of KLH by murine T-cell clones. Immunogenetics. 14: 415-22. PMID 6800947 DOI: 10.1007/BF00373321  0.372
1982 Dailey MO, Fathman CG, Butcher EC, Pillemer E, Weissman I. Abnormal migration of T lymphocyte clones. Journal of Immunology (Baltimore, Md. : 1950). 128: 2134-6. PMID 6460817  0.435
1982 Hodes RJ, Shigeta M, Hathcock KS, Fathman CG, Singer A. Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway. Journal of Immunology (Baltimore, Md. : 1950). 129: 267-71. PMID 6177752  0.37
1982 Infante AJ, Infante PD, Gillis S, Fathman CG. Definition of T cell idiotypes using anti-idiotypic antisera produced by immunization with T cell clones. The Journal of Experimental Medicine. 155: 1100-7. PMID 6174671 DOI: 10.1084/Jem.155.4.1100  0.435
1982 Infante AJ, Atassi MZ, Fathman CG. T cell clones reactive with sperm whale myoglobin. Isolation of clones with specificity for individual determinants on myoglobin. The Journal of Experimental Medicine. 154: 1342-56. PMID 6170716 DOI: 10.1084/JEM.154.5.1342  0.387
1981 Kimoto M, Krenz TJ, Fathman CG. Antigen-reactive T clones. III. Low responder antigen-presenting cells function effectively to present antigen to selected T cell clones derived from (High Responder x Low Responder)F1 mice. The Journal of Experimental Medicine. 154: 883-91. PMID 6456323 DOI: 10.1084/JEM.154.3.883  0.395
1981 McKean DJ, Infante AJ, Nilson A, Kimoto M, Fathman CG, Walker E, Warner N. Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells. The Journal of Experimental Medicine. 154: 1419-31. PMID 6170720 DOI: 10.1084/jem.154.5.1419  0.326
1981 Fathman CG, Kimoto M. Studies Utilizing murine T cell clones: Ir genes, Ia antigens and MLR stimulating determinants. Immunological Reviews. 54: 57-79. PMID 6166538 DOI: 10.1111/j.1600-065X.1981.tb00434.x  0.382
1981 Kimoto M, Fathman CG. Antigen-reactive T cell clones. II. Unique homozygous and (high responder x low responder)F1 hybrid antigen-presenting determinants detected using poly(Tyr, Glu)-poly D, L-Ala--poly Lys-reactive T cell clones. The Journal of Experimental Medicine. 153: 375-85. PMID 6165797 DOI: 10.1084/JEM.153.2.375  0.315
1981 Fathman CG, Kimoto M, Melvold R, David CS. Reconstitution of Ir genes, Ia antigens, and mixed lymphocyte reaction determinants by gene complementation. Proceedings of the National Academy of Sciences of the United States of America. 78: 1853-7. PMID 6165020 DOI: 10.1073/PNAS.78.3.1853  0.371
1980 Fathman CG, Weissman IL. Production of alloreactive T-cell lymphomas. Nature. 283: 404-6. PMID 6965424 DOI: 10.1038/283404a0  0.451
1980 Kimoto M, Fathman CG. Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation. The Journal of Experimental Medicine. 152: 759-70. PMID 6158548 DOI: 10.1084/JEM.152.4.759  0.361
1980 Fathman CG, Hengartner H. Crossreactive mixed lymphocyte reaction determinants recognized by cloned alloreactive T cells. Proceedings of the National Academy of Sciences of the United States of America. 76: 5863-6. PMID 93286 DOI: 10.1073/pnas.76.11.5863  0.39
1978 Fathman CG, Hengartner H. Clones of alloreactive T cells. Nature. 272: 617-8. PMID 306067 DOI: 10.1038/272617A0  0.459
1978 Watanabe T, Fathman CG, Coutinho A. T cells which proliferate in response to concanavalin A include cells which proliferate in mixed leucocyte reactions. European Journal of Immunology. 7: 603-7. PMID 144602 DOI: 10.1002/eji.1830070905  0.408
1977 Watanabe T, Fathman CG, Coutinho A. Clonal growth of T cells in vitro: preliminary attempts to a quantitative approach. Immunological Reviews. 35: 3-37. PMID 70399 DOI: 10.1111/j.1600-065X.1977.tb00233.x  0.353
1975 Fathman CG, Small M, Herzenberg LA, Weissman IL. Thymus cell maturation. II. Differentiation of three "mature" subclasses in vivo. Cellular Immunology. 15: 109-28. PMID 1109155 DOI: 10.1016/0008-8749(75)90169-0  0.364
1975 Cantor H, Simpson E, Sato VL, Fathman CG, Herzenberg LA. Characterization of subpopulations of T lymphocytes. I. Separation and functional studies of peripheral T-cells binding different amounts of fluorescent anti-Thy 1.2 (theta) antibody using a fluorescence-activated cell sorter (FACS). Cellular Immunology. 15: 180-96. PMID 1088903 DOI: 10.1016/0008-8749(75)90174-4  0.534
Show low-probability matches.